Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01962168 · ClinicalTrials.gov registry record
Evolution® Biliary Stent System Clinical Study
A clinical trial, sponsored by Cook Group Incorporated.
- Completed
- Registry status
- 113
- Enrollment target
NCT01962168 is a clinical trial that has completed, run by Cook Group Incorporated. The registered enrollment target is 113 participants.
The verdict
NCT01962168 has completed, sponsored by Cook Group Incorporated.
- COMPLETED
- Registry status
- 113 participants
- Enrollment target
Study Summary
The Evolution® Biliary Stent System Clinical Study is a clinical trial on a commercially available device to gather physician experience with the Cook Evolution® Biliary Stent System for the palliation of cancer in the biliary tree. Patients will be treated as per usual medical practices.
Interventions
- DEVICE Evolution® Biliary Stent - Uncovered
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 113 participants |
| Start Date | 2013-12 |
| Est. Completion | 2015-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01962168
The ClinicalTrials.gov registry entry for NCT01962168 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 113 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cook Group Incorporated, which has 31 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Evolution® Biliary Stent - Uncovered is the first listed.
NCT01962168 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01962168 about?
NCT01962168 is a clinical study titled "Evolution® Biliary Stent System Clinical Study". The Evolution® Biliary Stent System Clinical Study is a clinical trial on a commercially available device to gather physician experience with the Cook Evolution® Biliary Stent System for the palliation of cancer in the biliary tree. Patients will be treated as per usual medical practices.
What is the current status of trial NCT01962168?
This trial is currently completed. The enrollment target is 113 participants. The study started on 2013-12. Estimated completion is 2015-03.
What interventions are being tested in trial NCT01962168?
The interventions under investigation include: Evolution® Biliary Stent - Uncovered (DEVICE).
Who is sponsoring clinical trial NCT01962168?
This trial is sponsored by Cook Group Incorporated, which has 31 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.